• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

依诺沙星及其代谢产物氧氟沙星在健康志愿者排泄液中的分布动力学

Distribution kinetics of enoxacin and its metabolite oxoenoxacin in excretory fluids of healthy volunteers.

作者信息

Jaehde U, Sörgel F, Naber K G, Zürcher J, Schunack W

机构信息

Institute for Biomedical and Pharmaceutical Research, Nürnberg-Heroldsberg, Germany.

出版信息

Antimicrob Agents Chemother. 1995 Sep;39(9):2092-7. doi: 10.1128/AAC.39.9.2092.

DOI:10.1128/AAC.39.9.2092
PMID:8540722
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC162887/
Abstract

The distribution kinetics of enoxacin and its main metabolite oxoenoxacin in excretory fluids was investigated in 11 healthy volunteers. A single intravenous dose of 428 mg of enoxacin was given as a 1-h infusion. Serial samples of plasma, urine, saliva, nasal secretions, tears, and sweat were drawn and analyzed for enoxacin and oxoenoxacin by reversed-phase high-pressure liquid chromatography. Large differences in the concentration-time profiles of the excretory fluids analyzed were observed. Nasal secretions exhibited the highest enoxacin exposure, as assessed by the area under the concentration-time curve. Excretory fluid/plasma area under the concentration-time curve ratios were found to be 1.67 +/- 0.36 for nasal secretions, 0.76 +/- 0.28 for saliva, 0.25 +/- 0.07 for sweat, and 0.23 +/- 0.11 for tears. The elimination half-life of enoxacin from sweat (8.27 +/- 2.63 h) was significantly longer than that for plasma (5.10 +/- 0.46 h). Oxoenoxacin was detected in urine and saliva and exhibited a higher renal clearance and a lower saliva exposure than the parent compound. In contrast to that of the metabolite, distribution of enoxacin in saliva was found to be time and pH dependent. In conclusion, our study revealed considerable differences in the distribution kinetics of enoxacin among various excretory sites. Because of distinct acidic and basic properties, the anionic oxometabolite significantly differs from the zwitterionic parent compound in its distribution characteristics.

摘要

在11名健康志愿者中研究了依诺沙星及其主要代谢产物氧氟沙星在排泄液中的分布动力学。以1小时静脉输注的方式给予428mg依诺沙星单次静脉剂量。采集血浆、尿液、唾液、鼻分泌物、泪液和汗液的系列样本,并用反相高效液相色谱法分析其中的依诺沙星和氧氟沙星。观察到所分析的排泄液的浓度-时间曲线存在很大差异。通过浓度-时间曲线下面积评估,鼻分泌物中依诺沙星的暴露量最高。发现排泄液/血浆浓度-时间曲线下面积比,鼻分泌物为1.67±0.36,唾液为0.76±0.28,汗液为0.25±0.07,泪液为0.23±0.11。依诺沙星在汗液中的消除半衰期(8.27±2.63小时)明显长于血浆中的消除半衰期(5.10±0.46小时)。在尿液和唾液中检测到氧氟沙星,其肾清除率高于母体化合物,在唾液中的暴露量低于母体化合物。与代谢产物不同,发现依诺沙星在唾液中的分布与时间和pH值有关。总之,我们的研究揭示了依诺沙星在不同排泄部位的分布动力学存在显著差异。由于具有不同的酸性和碱性性质,阴离子型氧代谢产物在分布特征上与两性离子型母体化合物有显著差异。

相似文献

1
Distribution kinetics of enoxacin and its metabolite oxoenoxacin in excretory fluids of healthy volunteers.依诺沙星及其代谢产物氧氟沙星在健康志愿者排泄液中的分布动力学
Antimicrob Agents Chemother. 1995 Sep;39(9):2092-7. doi: 10.1128/AAC.39.9.2092.
2
Pharmacokinetics of enoxacin and its oxometabolite following intravenous administration to patients with different degrees of renal impairment.依诺沙星及其氧化代谢产物在不同程度肾功能损害患者静脉给药后的药代动力学。
Antimicrob Agents Chemother. 1990 Aug;34(8):1491-7. doi: 10.1128/AAC.34.8.1491.
3
Effect of probenecid on the distribution and elimination of ciprofloxacin in humans.丙磺舒对环丙沙星在人体内分布及消除的影响。
Clin Pharmacol Ther. 1995 Nov;58(5):532-41. doi: 10.1016/0009-9236(95)90173-6.
4
Effects of enoxacin on renal and metabolic clearance of theophylline in rats.依诺沙星对大鼠体内茶碱肾清除率及代谢清除率的影响。
Antimicrob Agents Chemother. 1990 Sep;34(9):1739-43. doi: 10.1128/AAC.34.9.1739.
5
A simple chromatographic method for determining norfloxacin and enoxacin in pharmacokinetic study assessing CYP1A2 inhibition.一种用于在评估CYP1A2抑制作用的药代动力学研究中测定诺氟沙星和依诺沙星的简单色谱方法。
Biomed Chromatogr. 2011 Apr;25(4):435-8. doi: 10.1002/bmc.1488.
6
Pharmacokinetics of intravenous and oral enoxacin in healthy volunteers.
J Antimicrob Chemother. 1988 Feb;21 Suppl B:49-56. doi: 10.1093/jac/21.suppl_b.49.
7
Simultaneous determination of theophylline, enoxacin and ciprofloxacin in human plasma and saliva by high-performance liquid chromatography.高效液相色谱法同时测定人血浆和唾液中的茶碱、依诺沙星和环丙沙星。
J Chromatogr B Biomed Appl. 1995 Jul 21;669(2):372-6. doi: 10.1016/0378-4347(95)00110-5.
8
Effects of oral cimetidine or ranitidine on the pharmacokinetics of intravenous enoxacin.
J Clin Pharmacol. 1993 Jan;33(1):53-6. doi: 10.1002/j.1552-4604.1993.tb03903.x.
9
A minor possibility of pharmacokinetic interaction between enoxacin and fenbufen in rats.依诺沙星与芬布芬在大鼠体内存在药代动力学相互作用的微小可能性。
J Pharmacobiodyn. 1990 Feb;13(2):90-6. doi: 10.1248/bpb1978.13.90.
10
Urinary bactericidal activity and pharmacokinetics of enoxacin versus norfloxacin and ciprofloxacin in healthy volunteers after a single oral dose.单次口服给药后,依诺沙星与诺氟沙星和环丙沙星在健康志愿者体内的尿杀菌活性及药代动力学比较
Int J Antimicrob Agents. 1998 Apr;10(1):31-8. doi: 10.1016/s0924-8579(98)00014-4.

本文引用的文献

1
The penetration of oral ciprofloxacin into the aqueous humor, vitreous, and subretinal fluid of humans.口服环丙沙星在人体房水、玻璃体及视网膜下液中的渗透情况。
Am J Ophthalmol. 1993 May 15;115(5):623-8. doi: 10.1016/s0002-9394(14)71460-6.
2
Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis.氟喹诺酮类抗菌剂在铜绿假单胞菌败血症中性粒细胞减少大鼠模型中的药效学
Antimicrob Agents Chemother. 1993 Mar;37(3):483-90. doi: 10.1128/AAC.37.3.483.
3
Pharmacokinetics of antibiotics in shallow and deep compartments.
J Antimicrob Chemother. 1993 May;31 Suppl D:17-27. doi: 10.1093/jac/31.suppl_d.17.
4
Bisubstrates: substances that interact with both, renal contraluminal organic anion and organic cation transport systems. II. Zwitterionic substrates: dipeptides, cephalosporins, quinolone-carboxylate gyrase inhibitors and phosphamide thiazine carboxylates; nonionizable substrates: steroid hormones and cyclophosphamides.双底物:与肾腔侧有机阴离子和有机阳离子转运系统均相互作用的物质。二、两性离子底物:二肽、头孢菌素、喹诺酮羧酸类回旋酶抑制剂和磷酰胺噻嗪羧酸盐;非离子化底物:甾体激素和环磷酰胺。
Pflugers Arch. 1993 Nov;425(3-4):300-12. doi: 10.1007/BF00374180.
5
Pharmacokinetic principles of drug distribution in saliva.药物在唾液中分布的药代动力学原理。
Ann N Y Acad Sci. 1993 Sep 20;694:36-47. doi: 10.1111/j.1749-6632.1993.tb18340.x.
6
Factors influencing the saliva/plasma ratio of drugs.影响药物唾液/血浆比值的因素。
Ann N Y Acad Sci. 1993 Sep 20;694:128-42. doi: 10.1111/j.1749-6632.1993.tb18347.x.
7
Effective monitoring of concentrations of ofloxacin in saliva of patients with chronic respiratory tract infections.慢性呼吸道感染患者唾液中氧氟沙星浓度的有效监测。
Antimicrob Agents Chemother. 1994 May;38(5):1140-3. doi: 10.1128/AAC.38.5.1140.
8
Effect of saliva flow rate on saliva phenytoin concentrations: implications for therapeutic monitoring.唾液流速对唾液中苯妥英浓度的影响:对治疗监测的意义。
Eur J Clin Pharmacol. 1994;46(6):565-7. doi: 10.1007/BF00196118.
9
The influence of protein binding upon tissue fluid levels of six beta-lactam antibiotics.蛋白质结合对六种β-内酰胺类抗生素组织液水平的影响。
J Infect Dis. 1980 Jul;142(1):77-82. doi: 10.1093/infdis/142.1.77.
10
Pharmacokinetics and tissue penetration of enoxacin.依诺沙星的药代动力学和组织穿透性。
Antimicrob Agents Chemother. 1984 Jul;26(1):17-9. doi: 10.1128/AAC.26.1.17.